Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study.
Zelic R, Zugna D, Bottai M, Andrén O, Fridfeldt J, Carlsson J, Davidsson S, Fiano V, Fiorentino M, Giunchi F, Grasso C, Lianas L, Mascia C, Molinaro L, Zanetti G, Richiardi L, Pettersson A, Akre O. Zelic R, et al. Among authors: giunchi f. Am J Epidemiol. 2019 Jun 1;188(6):1165-1173. doi: 10.1093/aje/kwz026. Am J Epidemiol. 2019. PMID: 30976789 Free PMC article.
Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings.
Brunocilla E, Ceci F, Schiavina R, Castellucci P, Maffione AM, Cevenini M, Bianchi L, Borghesi M, Giunchi F, Fiorentino M, Chondrogiannis S, Colletti PM, Rubello D, Fanti S, Martorana G. Brunocilla E, et al. Among authors: giunchi f. Clin Nucl Med. 2014 May;39(5):e308-12. doi: 10.1097/RLU.0000000000000342. Clin Nucl Med. 2014. PMID: 24458183
Revised Gleason grading system is a better predictor of indolent prostate cancer at the time of diagnosis: retrospective clinical-pathological study on matched biopsy and radical prostatectomy specimens.
Giunchi F, Brunocilla E, Borghesi M, Rizzi S, Ricci MS, Romagnoli D, Martorana G, Schiavina R, Fiorentino M. Giunchi F, et al. Clin Genitourin Cancer. 2014 Oct;12(5):325-9. doi: 10.1016/j.clgc.2014.01.009. Epub 2014 Feb 4. Clin Genitourin Cancer. 2014. PMID: 24583160
Nodal occult metastases in intermediate- and high-risk prostate cancer patients detected using serial section, immunohistochemistry, and real-time reverse transcriptase polymerase chain reaction: prospective evaluation with matched-pair analysis.
Schiavina R, Capizzi E, Borghesi M, Vagnoni V, Romagnoli D, Rocca GC, Giunchi F, D'Errico A, De Giovanni A, Rizzi S, Brunocilla E, Martorana G, Fiorentino M. Schiavina R, et al. Among authors: giunchi f. Clin Genitourin Cancer. 2015 Apr;13(2):e55-64. doi: 10.1016/j.clgc.2014.08.004. Epub 2014 Aug 9. Clin Genitourin Cancer. 2015. PMID: 25212578
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates.
Schiavina R, Borghesi M, Brunocilla E, Romagnoli D, Diazzi D, Giunchi F, Vagnoni V, Pultrone CV, Dababneh H, Porreca A, Fiorentino M, Martorana G. Schiavina R, et al. Among authors: giunchi f. Prostate Cancer Prostatic Dis. 2015 Sep;18(3):270-5. doi: 10.1038/pcan.2015.21. Epub 2015 Jun 9. Prostate Cancer Prostatic Dis. 2015. PMID: 26055663
117 results